✦ LIBER ✦

Editorial Comment on: Docetaxel-Based Chemotherapy in Elderly Patients (Age 75 and Older) with Castration-Resistant Prostate Cancer

✍ Scribed by Mark A. Rosenthal

Book ID: 113611019
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 85 KB
Volume: 55
Category: Article
ISSN: 0302-2838
DOI: 10.1016/j.eururo.2008.07.079

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Docetaxel-Based Chemotherapy in Elderly

Docetaxel-Based Chemotherapy in Elderly Patients (Age 75 and Older) with Castration-Resistant Prostate Cancer

✍ Antoine Italiano; Cécile Ortholan; Stéphane Oudard; Damien Pouessel; Gwenaëlle G 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 220 KB

Docetaxel-based systemic chemotherapy in

Docetaxel-based systemic chemotherapy in elderly Korean men with castration-resistant prostate cancer

✍ S.C.H. Park; L.J. Whan; R.J. Sik 📂 Article 📅 2012 🏛 Elsevier ⚖ 236 KB

761 PREDICTION OF LEUKOPENIA AFTER DOCET

761 PREDICTION OF LEUKOPENIA AFTER DOCETAXEL CHEMOTHERAPY IN PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER

✍ Nakashima, Jun; Takizawa, Issei; Ko, Kazuyoshi; Nakagami, Yoshihiro; Ohori, Mako 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 96 KB

Phase II study of personalized peptide v

Phase II study of personalized peptide vaccination for castration-resistant prostate cancer patients who failed in docetaxel-based chemotherapy

✍ Masanori Noguchi; Fukuko Moriya; Shigetaka Suekane; Kei Matsuoka; Gaku Arai; Sat 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 259 KB

Impact of docetaxel-based chemotherapy o

Impact of docetaxel-based chemotherapy on quality of life of patients with castration-resistant prostate cancer: results from a prospective phase II randomized trial

✍ Orazio Caffo; Teodoro Sava; Evi Comploj; Annamaria Fariello; Fable Zustovich; Ro 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 415 KB

Ability of C-reactive protein to complem

Ability of C-reactive protein to complement multiple prognostic classifiers in men with metastatic castration resistant prostate cancer receiving docetaxel-based chemotherapy

✍ Gregory R. Pond; Andrew J. Armstrong; Brian A. Wood; Lance Leopold; Matthew D. G 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB